Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP420982.RAJIzDlXNOtpnlj6IVEOOG8e43fiAAEOJn6Mk0-U3o08U130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP420982.RAJIzDlXNOtpnlj6IVEOOG8e43fiAAEOJn6Mk0-U3o08U130_assertion type Assertion NP420982.RAJIzDlXNOtpnlj6IVEOOG8e43fiAAEOJn6Mk0-U3o08U130_head.
- NP420982.RAJIzDlXNOtpnlj6IVEOOG8e43fiAAEOJn6Mk0-U3o08U130_assertion description "[This study is first to report that the XRCC1 and XRCC3 gene polymorphisms are useful as a surrogate marker of clinical outcome in colorectal cancer with 5-FU/oxaliplatin combination chemotherapy in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP420982.RAJIzDlXNOtpnlj6IVEOOG8e43fiAAEOJn6Mk0-U3o08U130_provenance.
- NP420982.RAJIzDlXNOtpnlj6IVEOOG8e43fiAAEOJn6Mk0-U3o08U130_assertion evidence source_evidence_literature NP420982.RAJIzDlXNOtpnlj6IVEOOG8e43fiAAEOJn6Mk0-U3o08U130_provenance.
- NP420982.RAJIzDlXNOtpnlj6IVEOOG8e43fiAAEOJn6Mk0-U3o08U130_assertion SIO_000772 22580644 NP420982.RAJIzDlXNOtpnlj6IVEOOG8e43fiAAEOJn6Mk0-U3o08U130_provenance.
- NP420982.RAJIzDlXNOtpnlj6IVEOOG8e43fiAAEOJn6Mk0-U3o08U130_assertion wasDerivedFrom befree-20140225 NP420982.RAJIzDlXNOtpnlj6IVEOOG8e43fiAAEOJn6Mk0-U3o08U130_provenance.
- NP420982.RAJIzDlXNOtpnlj6IVEOOG8e43fiAAEOJn6Mk0-U3o08U130_assertion wasGeneratedBy ECO_0000203 NP420982.RAJIzDlXNOtpnlj6IVEOOG8e43fiAAEOJn6Mk0-U3o08U130_provenance.